The unmet need for addressing cardiac issues in intensive care research

Sean van Diepen1, Christopher B Granger, Michael Jacka

  • 11Divisions of Critical Care and Cardiology, University of Alberta, Edmonton, Alberta, Canada. 2Duke Clinical Research Institute, Duke University Medical Center, Durham, NC. 3Division of Critical Care, University of Alberta, Edmonton, Alberta, Canada. 4Milton S. Hershey Medical Center, Penn State University, Hershey, PA. 5Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. 6Divisions of Cardiology and Pulmonary and Critical Care Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.

Critical Care Medicine
|September 23, 2014
PubMed

Insights

Critically ill cardiac patients are frequently admitted to intensive care units (ICUs), yet cardiac research in these ICUs is notably scarce. This study reveals a significant gap in cardiac-specific studies and funding compared to other critical care research areas.

Area of Science:

  • Critical Care Medicine
  • Cardiovascular Research
  • Clinical Trials Analysis

Background:

  • Cardiovascular disorders are common among intensive care unit (ICU) patients.
  • There is limited understanding of the extent of cardiac research within adult ICUs.

Purpose of the Study:

  • To assess the proportion of cardiac-specific research among adult ICU studies.
  • To identify the focus of current clinical trials and research grants related to ICU patients.

Main Methods:

  • Retrospective analysis of clinical trials from ClinicalTrials.gov (1999-2012).
  • Review of funding grants from the Canadian Institutes for Health Research (1999-2012).
  • Identification of studies involving adult ICU patients and cardiac interventions or outcomes.

Main Results:

  • Out of 192 studies in ClinicalTrials.gov, only 4.6% were cardiac-specific.
  • Of 105 Canadian Institutes for Health Research grants, only 1.9% focused on cardiac research.
  • Respiratory, infectious, and neurologic research were more prevalent than cardiac research in ICUs.

Conclusions:

  • A significant disparity exists between the prevalence of cardiac disease in ICUs and the amount of cardiac-specific research conducted.
  • This underrepresentation highlights a need for increased research focus on critically ill cardiac patients to improve outcomes.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
775
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
743
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
514
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
626
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
476
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
777